The post Investing in AI, health tech appeared on BitcoinEthereumNews.com. Giorgos Tsetis, cofounder and former CEO of Nutrafol. Courtesy of Great Things A versionThe post Investing in AI, health tech appeared on BitcoinEthereumNews.com. Giorgos Tsetis, cofounder and former CEO of Nutrafol. Courtesy of Great Things A version

Investing in AI, health tech

Giorgos Tsetis, cofounder and former CEO of Nutrafol.

Courtesy of Great Things

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox.

After struggling with hair loss in his 20s, Giorgos Tsetis co-founded Nutrafol in 2014 to make supplements that address hair growth. Early this year, Tsetis sold his remaining equity at a valuation of $3.5 billion to Unilever and stepped down as Nutrafol’s CEO.

The 41-year-old told Inside Wealth he had two goals for his next chapter: to leave a better world for his young children and invest in companies with an eye toward social good.

“Early on, I had investors who made hundreds and hundreds of millions of dollars by essentially doing nothing. I just made wealthier people wealthier, and there’s nothing wrong with that,” he said in an interview. However, as a founder, he said he would have appreciated knowing that his success was also supporting causes like food access and mental health.

Six months ago, Tsetis launched his family office, Great Things, with the goal of using his investment profits to fund his philanthropy. He represents a growing class of ultra-wealthy millennials such as Walmart heir Lukas Walton who are setting up family offices early in life to promote causes like sustainability over sheer wealth preservation. And while many corporate asset managers have dialed back their impact investing, family offices largely haven’t, and next-generation principals are expected to double down on environmentally or socially conscious investing.

“I think the last thing you want to hand over to your children is wealth. I don’t necessarily think that is beneficial, even though we may think that that’s true,” Tsetis said. “I want to make impact now, and what I am excited about is to involve my children in those processes so they can see what’s happening in the world.”

Tsetis designed Great Things with a for-profit and a nonprofit arm, with the goal of using investment returns to fund charities that support causes like mental health and crisis response. Tsetis said a “significant portion” of the venture unit’s returns would go to philanthropy but declined to specify a percentage.

Tsetis began early-stage startup investing in earnest after Nutrafol’s Series B funding in 2019 and ramped it up after Unilever bought a majority stake in 2022. His portfolio includes artificial intelligence-driven companies focused on health care, like longevity startup NewLimit and BreakBio, a developer of personalized cancer vaccines.

His investment lens isn’t squarely focused on impact, having backed Anthropic, xAI and SpaceX. Tsetis acknowledged he has concerns about the ramifications of AI. “ChatGPT knows more about me than I know about myself, and that’s a problem,” he added. But Tsetis said early-stage investing makes it easier for him to get a seat at the table.

“You don’t know where the future is going to go,” he said. “I’d rather participate than be a spectator, and, wherever I can, drive and steer those conversations, because I do think that we need to prioritize human well-being.”

Tsetis’ ultimate goal is to give his portfolio companies a voice in how Great Things’ investment returns are donated.

Get Inside Wealth directly to your inbox

“Imagine if Nutrafol was able to deploy a million dollars at their choice,” he said. “That could have been quite interesting.”

Great Things has six full-time employees thus far, and Tsetis’s wife, Cerelina Proesl, advises on philanthropy. The family office has backed nonprofits including Every Cure, which uses artificial intelligence to identify existing drugs to treat rare diseases, and Ubuntu Pathways, a provider of education and HIV treatment in South Africa.

Tsetis said he hopes that other investors strategize on how to give back rather than doing so as an afterthought.

Social responsibility “should be something that people can get very excited about,” he said. “I’m hopeful that people want to do something about this problem that we currently experience, which is wealth concentration.”

Source: https://www.cnbc.com/2025/12/18/nutrafol-founder-giorgos-tsetis-philanthrophy.html

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

What Does Market Cap Really Mean in Crypto — and Why Australians Care

What Does Market Cap Really Mean in Crypto — and Why Australians Care

Introduction: What Does Market Cap Mean in Cryptocurrency Ridgewell Tradebit is an automated cryptocurrency trading platform that helps users better understand
Share
Techbullion2026/02/09 23:34
The Manchester City Donnarumma Doubters Have Missed Something Huge

The Manchester City Donnarumma Doubters Have Missed Something Huge

The post The Manchester City Donnarumma Doubters Have Missed Something Huge appeared on BitcoinEthereumNews.com. MANCHESTER, ENGLAND – SEPTEMBER 14: Gianluigi Donnarumma of Manchester City celebrates the second City goal during the Premier League match between Manchester City and Manchester United at Etihad Stadium on September 14, 2025 in Manchester, England. (Photo by Visionhaus/Getty Images) Visionhaus/Getty Images For a goalkeeper who’d played an influential role in the club’s first-ever Champions League triumph, it was strange to see Gianluigi Donnarumma so easily discarded. Soccer is a brutal game, but the sudden, drastic demotion of the Italian from Paris Saint-Germain’s lineup for the UEFA Super Cup clash against Tottenham Hotspur before he was sold to Manchester City was shockingly brutal. Coach Luis Enrique isn’t a man who minces his words, so he was blunt when asked about the decision on social media. “I am supported by my club and we are trying to find the best solution,” he told a news conference. “It is a difficult decision. I only have praise for Donnarumma. He is one of the very best goalkeepers out there and an even better man. “But we were looking for a different profile. It’s very difficult to take these types of decisions.” The last line has really stuck, especially since it became clear that Manchester City was Donnarumma’s next destination. Pep Guardiola, under whom the Italian will be playing this season, is known for brutally axing goalkeepers he didn’t feel fit his profile. The most notorious was Joe Hart, who was jettisoned many years ago for very similar reasons to Enrique. So how can it be that the Catalan coach is turning once again to a so-called old-school keeper? Well, the truth, as so often the case, is not quite that simple. As Italian soccer expert James Horncastle pointed out in The Athletic, Enrique’s focus on needing a “different profile” is overblown. Lucas Chevalier,…
Share
BitcoinEthereumNews2025/09/18 07:38
DeFi Technologies' Valour Launches New Bitcoin-Collateralized ETP on London Stock Exchange

DeFi Technologies' Valour Launches New Bitcoin-Collateralized ETP on London Stock Exchange

PANews reported on September 19th that, as the UK gradually relaxes restrictions on digital assets, Valour, a subsidiary of DeFi Technologies, launched a Bitcoin-collateralized ETP on the London Stock Exchange, offering investors the opportunity to earn cryptocurrency returns. This Bitcoin-collateralized ETP offers an annual yield of 1.4%, backed by Bitcoin held in cold wallets and secured by multi-party computation (MCP) technology. Currently, this new Bitcoin-collateralized ETP is only available to institutional and professional investors. The UK will allow retail investors to purchase cryptocurrency ETNs again on October 8, lifting a ban in place since 2021. The announcement did not specify how returns will be generated. However, another Bitcoin ETP listed by Valour on a French exchange generates Bitcoin returns by delegating tokens on Core Chain.
Share
PANews2025/09/19 08:09